{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:15:03Z","timestamp":1779927303373,"version":"3.53.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:00:00Z","timestamp":1377648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072794","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T21:10:09Z","timestamp":1377724209000},"page":"e72794","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants"],"prefix":"10.1371","volume":"8","author":[{"given":"Stephanie A.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Groome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthonet","family":"Koen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Van Niekerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Sewraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Locadiah","family":"Kuwanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alane","family":"Izu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Adrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,28]]},"reference":[{"key":"ref1","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper-2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1016\/j.vaccine.2011.07.042","article-title":"Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis","volume":"29","author":"P Scott","year":"2011","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1016\/j.vaccine.2011.09.011","article-title":"Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: a systematic review and meta-analysis","volume":"29","author":"S R\u00fcckinger","year":"2011","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0b013e3181c67f04","article-title":"Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom","volume":"29","author":"D Goldblatt","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"S Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"KP Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"FT Cutts","year":"2005","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","article-title":"Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine","volume":"25","author":"SA Madhi","year":"2007","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QAD.0b013e328341b7f1","article-title":"The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis","volume":"25","author":"MC Nunes","year":"2011","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/597388","article-title":"Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination","volume":"199","author":"SA Madhi","year":"2009","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"S Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"L J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/653704","article-title":"Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants","volume":"202","author":"SA Madhi","year":"2010","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.vaccine.2012.11.076","article-title":"Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants","volume":"31","author":"SA Madhi","year":"2013","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"KP Klugman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.vaccine.2012.05.059","article-title":"The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with a 7-valent pneumococcal conjugate vaccine on a pneumococcal carriage: a randomized controlled trial","volume":"30","author":"R Dagan","year":"2012","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diagmicrobio.2011.07.006","article-title":"Serotype and antimicrobial profile distribution of invasive pneumococcal isolated in the pre-vaccine introduction era in Pretoria, South Africa, 2005-2009","volume":"71","author":"EJ Silberbauer","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTaP-Hib: impact of IPV and coadninistration of CRM197 conjugates","volume":"7","author":"R Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of Antibody Response to an 11-Valent Pneumococcal Vaccine Coadministered with a Vaccine Containing Acellular Pertussis Components","volume":"72","author":"R Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"21","author":"HJ Schmitt","year":"2003","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.vaccine.2006.03.032","article-title":"The immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTaP\u2013HBV\u2013IPV\/Hib combination vaccine in healthy infants","volume":"24","author":"M Knuf","year":"2006","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of Rountiely Used Chilhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typable Heamophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)","volume":"28","author":"M Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"C21","DOI":"10.1016\/j.vaccine.2012.05.055","article-title":"Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy","volume":"7","author":"SA Madhi","year":"2012","journal-title":"Vaccine"},{"key":"ref24","article-title":"Effectiveness of Pneumococcal Conjugate Vaccine against presumed bacterial pneumonia (PBP) in South African HIV-uninfected children: A Case-Contril Study. Abstract 304","author":"SA Madhi","year":"2012"},{"key":"ref25","article-title":"Out of Africa: Lessons Learnt and Challenges in Evaluating the Effectivementt of Pneumococcal Conjugate Vaccine. Abstract 16","author":"SA Mahdi","year":"2012"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T19:02:53Z","timestamp":1596394973000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072794"}},"subtitle":[],"editor":[{"given":"Bernard","family":"Beall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,28]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072794","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,28]]}}}